Dexmedetomidine Versus Hyalase Treatment of Carpal Tunnel Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-01

Study Completion Date

2023-08-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Carpal tunnel syndrome (CTS) is a common peripheral entrapment neuropathy, this study aims to investigate if, and to what extent hydro-dissection hyalase and saline versus dexmedetomidine upon the median nerve could offer symptoms and clinical improvement

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dexmedetomidine Versus Triamcinolone Treatment in Carpal Tunnel Syndrome

NCT05624866

Carpal Tunnel Syndrome

UNKNOWN NA

Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome

NCT04961281

Chronic Pain Carpal Tunnel Syndrome

COMPLETED NA

Median Nerve Hydro-dissection Using Single Injection of Hyalase as a Novel Treatment of Carpal Tunnel Syndrome

NCT03177915

Carpal Tunnel Syndrome Pain, Chronic

COMPLETED NA

Efficacy of Hyalase Hydro-dissection in Treatment of Carpal Tunnel: Randomized Double Blind Controlled Clinical Trial

NCT03675295

Carpal Tunnel Syndrome

COMPLETED NA

Hyaluronic Acid Hydro-dissection Use in Idiopathic Carpal Tunnel Syndrome Guided by Ultrasonic Study

NCT03180125

Carpal Tunnel Syndrome

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Carpal tunnel syndrome (CTS) is the most common compression syndrome the upper extremities. Its problem has a high prevalence ranged estimated prevalence of 3.8% in the general population, 3 and 7.8% in the working population. It occurs at any age, especially in individuals in their 40s to 60s, and the male: female ratio is reported to be 3:7. A lot of treatment modalities have been tried to improve the condition, starting from local anesthetic injection, steroid, and up to surgical decompression of the nerves.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome Pain, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dexmeditomidine group

injection of 1 microgram/kg dexmedetomidine + 10 cc saline injection nearby median nerve as hydrodissection

Group Type ACTIVE_COMPARATOR

Dexmedetomidine

Intervention Type DRUG

injection of 1 microgram/kg dexmeditomidine + 10 cc saline injection nearby median nerve as hydrodissection

Hyalase

injection of Hyalase + 10 cc saline injection nearby median nerve as hydro-dissection

Group Type ACTIVE_COMPARATOR

Hyalase

Intervention Type DRUG

injection of Hyalase + 10 cc saline injection nearby median nerve as hydro-dissection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.